Table of Content
-
Introduction
-
Report scopes
-
Inclusion, Exclusion Criteria and Assumptions
-
Executive Summary
-
Multi-scenario Market Forecast to 2027
-
Global Market Analysis
-
Regional Market Analysis
-
North America (The USA, Canada)
-
Europe (Germany, France, Spain, Italy) and UK
-
Asia (Japan, South Korea)
-
BRIC (Brazil, Russia, India, China)
-
Market size by Drug Class
-
Revenue Forecast by Molecular Target Class
-
Market Dynamics
-
Regulatory Landscape
-
Key Marketed Products
-
Overview
-
Catalyst
-
Pipeline Landscape Assessment
-
Overview
-
Pipeline Development Landscape
-
Attribute Analysis
-
Pipeline Valuation Analysis (Late-Stage Products)
-
Clinical Trials Analytics
-
Clinical Trial Failure Rates
-
Clinical Trial Duration
-
Clinical Trial Size
-
Value Chain
-
Supply Chain Analysis
-
COVID-19 Impact Analysis
-
Burning Issues
-
R&D Strategies
-
Overview
-
R&D strategies from business perspective
-
Label Expansions into Other Line of Therapy
-
Company Analysis and Positioning
-
Competitive Assessment
-
Company information (Funding/investment analysis)
-
Key & Established players
-
Upcoming/Start-ups
-
Marketed and Pipeline Portfolio Analysis
-
Strategic Consolidations
-
Licensing Deals
-
Co-development Deals
-
Key Opportunities
-
Unmet Needs
-
Opportunity Assessment
-
About us
-
Research Methodology
-
Bibliography